Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis

Thyroid

Volumn 6, Issue 4, 1996, Pages 301-304

  Daumerie, Ch ^a   Vynckier, S ^a   Caussin, J ^a   Jadoul, M ^a   Squifflet, J P ^a   De Patoul, N ^a   Wambersie, A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IODINE 131; PREDNISOLONE; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; HALF LIFE TIME; HEMODIALYSIS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RADIOACTIVITY; RENOVASCULAR DISEASE; THYROID CARCINOMA; THYROIDECTOMY;

EID: 0029747146     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1996.6.301     Document Type: Article

References (16)

1. Mazzaferri EL 1991 Treating of differentiated thyroid carcinoma: Where do we draw the line? Mayo Clin Proc 66:105-111.
2. Maxon HR, Thomas SR, Hertzberg VS, et al. 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937-941.
3. Howard N, Glasser M 1981 Iodine 131 ablation therapy for a patient on maintenance haemodialysis. Br J Radiol 54:259.
4. Morrish DW, Filipow LJ, McEwan AJ, Schmidt R, Murland KR, von Westarp C, Betcher KB 1990 131 Treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer 66:2509-2513.
5. Nibhanupudy JR, Hamilton W, Sridhar R, Talley GB, Chughtai GM, Ashayeri E, Goldson AL 1993 Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure. Am J Nephrol 13:214-217.
6. Mello AM, Isaacs R, Petersen J, Kronenberger S, McDougall IR 1994 Management of thyroid papillary carcinoma with radioiodine in a patient with end-stage renal disease on hemodialysis. Clin Nucl Med 19:776-781.
7. Veall N, Vetter H 1958 Radioisotope Techniques in Clinical Research and Diagnosis. Butterworths, London, pp 279-317.
8. Culpepper RM, Chang DA 1992 Radiation exposure from radionuclide use in dialysis patients. Semin Dial 5:129-135.
9. Culpepper RM, Hirsch JI, Fratkin MJ 1992 Clearance of 1-131 by hemodialysis. Clin Nephrol 38:110-114.
10. Maruca J, Santner S, Miller K, Santen RJ 1984 Prolonged iodine clearance with a depletion regimen for thyroid carcinoma. J Nucl Med 25:1089-1093.
11. Benua RS, Cicale NR, Sonenberg M, Rawson RW 1962 The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol 87:171-182.
12. Links JM, Wagner HN 1991 Radiation physics. In: Braverman LE, Utiger RD (eds) The Thyroid. Lippincott, Philadelphia, pp 405-20.
13. The International Commission on Radiological Protection 1988 Publication 53 Radiation Dose to Patients from Radiopharmaceuticals. Pergamon Press, New York, pp 259-278.
14. Becker DV, Hurley JR 1988 Radioiodine treatment of hyperthyroidism. In: Gottschalk A, Hoffer PB (eds) Diagnostic Radiology Series. Williams Wilkins, Baltimore, vol 2, pp 778-791.
15. Perry WF, Hughes JFS 1952 The urinary excretion and thyroid uptake of iodine in renal disease. J Clin Invest 31:457-463.
16. Edmonds CJ, Smith T, Barnaby CF 1970 Follow-up of thyroid carcinoma by whole-body counting. Br J Radiol 43:868-875.